Lionshead Wealth Management LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 714 shares of the healthcare conglomerate's stock, valued at approximately $361,000.
Other institutional investors also recently added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at $30,000. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Trading Down 1.0%
NYSE UNH traded down $3.03 on Wednesday, hitting $308.35. The company's stock had a trading volume of 37,577,107 shares, compared to its average volume of 5,117,656. The company's 50-day moving average is $482.53 and its 200 day moving average is $519.28. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $283.19 and a 1-year high of $630.73. The firm has a market cap of $279.72 billion, a PE ratio of 19.89, a PEG ratio of 1.37 and a beta of 0.56.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company posted $6.91 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 2.72%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 35.18%.
Analysts Set New Price Targets
UNH has been the subject of a number of analyst reports. Royal Bank of Canada cut their price objective on UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Hsbc Global Res lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Truist Financial decreased their target price on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a report on Monday, April 21st. Finally, HSBC restated a "hold" rating and set a $490.00 target price on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Six research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $523.52.
Check Out Our Latest Report on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.